Nitric oxide-dependent synthesis of vascular endothelial growth factor is impaired by high glucose

被引:13
作者
Dulak, J
Tomala, K
Loboda, A
Józkowicz, A
机构
[1] Jagiellonian Univ, Dept Cell Biochem, Fac Biotechnol, PL-30387 Krakow, Poland
[2] Jagiellonian Univ, Dept Mol Genet, Fac Biotechnol, Krakow, Poland
关键词
diabetes; inflammation; reactive oxygen species; atherosclerosis;
D O I
10.1016/j.lfs.2004.05.021
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Synthesis of vascular endothelial growth factor (VEGF), the major angiogenic molecule, is induced by nitric oxide (NO) in various cell types, including vascular smooth muscle cells (VSMC). Therefore, compounds which inhibit NO generation can also influence VEGF synthesis. Here we investigated the effect of increased glucose concentration (25 mM vs. 5.5 mM) on cytokine-induced VEGF synthesis in rat VSMC. The cells growing in the medium containing 5.5 mM glucose and exposed to IL-1-beta, TNF-alpha and IFN-gamma induced expression of an inducible isoform of nitric oxide synthase (NOS II). This is followed by generation of NO and the concomitant expression of VEGF gene and release of VEGF protein. In contrast, 25 mM glucose impaired induction of NOS II expression and thus NO synthesis was lower than in 5.5 mM glucose. Consequently, the VEGF promoter activation was attenuated, resulting in decreased mRNA synthesis and lower production of VEGF protein. The results indicate that abnormally high concentrations of glucose can impair generation of NO and the NO-dependent VEGF synthesis. This may play a role in the development and progression of vascular dysfunctions in cardiovascular diseases. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:2573 / 2586
页数:14
相关论文
共 45 条
[1]   High glucose and insulin inhibit VSMC MKP-1 expression by blocking iNOS via p38 MAPK activation [J].
Begum, N ;
Ragolia, L .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2000, 278 (01) :C81-C91
[2]   Commentary - Glucose, VEGF-A, and diabetic complications [J].
Benjamin, LE .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (04) :1181-1184
[3]   Hyperglycemic switch from mitochondrial nitric oxide to superoxide production in endothelial cells [J].
Brodsky, SV ;
Gao, SJ ;
Li, H ;
Goligorsky, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2002, 283 (05) :H2130-H2139
[4]   Modulation of VEGF production by pH and glucose in retinal Muller cells [J].
Brooks, SE ;
Gu, XL ;
Kaufmann, PM ;
Marcus, DM ;
Caldwell, RB .
CURRENT EYE RESEARCH, 1998, 17 (09) :875-882
[5]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[6]   Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products [J].
Chakravarthy, U ;
Hayes, RG ;
Stitt, AW ;
McAuley, E ;
Archer, DB .
DIABETES, 1998, 47 (06) :945-952
[7]   Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states - A possible explanation for impaired collateral formation in cardiac tissue [J].
Chou, E ;
Suzuma, I ;
Way, KJ ;
Opland, D ;
Clermont, AC ;
Naruse, K ;
Suzuma, K ;
Bowling, NL ;
Vlahos, CJ ;
Aiello, LP ;
King, GL .
CIRCULATION, 2002, 105 (03) :373-379
[8]  
Cosentino F, 1997, CIRCULATION, V96, P25
[9]   Regulation of vascular endothelial growth factor synthesis by nitric oxide:: Facts and controversies [J].
Dulak, J ;
Józkowicz, A .
ANTIOXIDANTS & REDOX SIGNALING, 2003, 5 (01) :123-132
[10]   Nitric oxide and angiogenic activity of endothelial cells:: direct or VEGF-dependent effect? [J].
Dulak, J ;
Józkowjcz, A .
CARDIOVASCULAR RESEARCH, 2002, 56 (03) :487-488